Takeda Pharmaceutical
TAK
#332
Rank
HK$545.21 B
Marketcap
HK$170.65
Share price
1.68%
Change (1 day)
55.61%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2026 (TTM): HK$4.56

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$4.57. an increase over its 2025 EPS that were of HK$1.79.

EPS history for Takeda Pharmaceutical from 2000 to 2026

Annual EPS

Year EPS Change
2026HK$3.0168.37%
2025HK$1.79-25.03%
2024HK$2.38-60.3%
2023HK$6.0026.77%
2022HK$4.74-44.4%
2021HK$8.52722.5%
2020HK$1.04-79.14%
2019HK$4.97-43.73%
2018HK$8.8270.24%
2017HK$5.1845.47%
2016HK$3.56-158.86%
2015-HK$6.05-217.99%
2014HK$5.13-34.43%
2013HK$7.825.17%
2012HK$7.44-49.61%
2011HK$14.76-6.27%
2010HK$15.7536.82%
2009HK$11.51-28.28%
2008HK$16.0524.96%
2007HK$12.859.24%
2006HK$11.763.21%
2005HK$11.40-6.29%
2004HK$12.1618.8%
2003HK$10.2430.39%
2002HK$7.8552.45%
2001HK$5.151.77%
2000HK$5.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36 1,046.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.15 801.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57 21.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.24 2,884.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$15.53 240.04%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$7.78 70.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.56 394.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$31.43-788.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$2.84-37.83%๐Ÿ‡ฎ๐Ÿ‡ณ India